Chemokine and cytokine production in the airway from atopic asthmatics after segmental allergen challenge

C. Pilette, J. Francis, S. Till, S. R. Durham (London, United Kingdom)

Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways
Session: Modulation of bronchial hyperreactivity and immune response in the airways
Session type: Oral Presentation
Number: 2445
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Pilette, J. Francis, S. Till, S. R. Durham (London, United Kingdom). Chemokine and cytokine production in the airway from atopic asthmatics after segmental allergen challenge. Eur Respir J 2003; 22: Suppl. 45, 2445

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Expression of CCR3 in bronchial biopsies after allergen challenge in subjects with atopic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 5s
Year: 2002

CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge
Source: Eur Respir J 2004; 23: 876-884
Year: 2004



Markers of inflammation and airway responses to allergen in asthmatic patients
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism.
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 217s
Year: 2002

Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459
Source: Eur Respir J 2013; 41: 46-52
Year: 2013



The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004

A single nasal allergen challenge increases induced sputum inflammatory parameters in non-asthmatic patients with seasonal allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001

Sputum CC-chemokines, IL-13 and pulmonary function in allergic asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 396s
Year: 2004

The possible role of IL-5 and IFN-γ in the forming of cold airway hyperresponsiveness in patients with bronchial asthma
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008

Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001

Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice
Source: Eur Respir J 2006; 28: Suppl. 50, 224s
Year: 2006

Effect of nasal allergen challenge on non-invasive markers of inflammation in allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 592s
Year: 2006

Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure
Source: Eur Respir J 2004; 24 : 750-757
Year: 2004



IFNg, IL4 and TGFb in nasal lavage fluid of perennial allergic rhinitis patients and IL4 and TGFb in induced sputum of atopic asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 735s
Year: 2005

The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2004; 24: Suppl. 48, 595s
Year: 2004

Inhaled IL-4/IL-13 antagonist decreases response to antigen challenge in atopic asthmatic subjects
Source: Eur Respir J 2007; 30: Suppl. 51, 490s
Year: 2007